Maureen joined PIR’s Board in 2018 to support the strategic growth of the company; becoming NEC in June 2019 as part of the company restructuring. She brings a wealth of leadership and industry experience; both from her GSK career, ultimately as VP Global Strategy Development, and more recently in the early stage, entrepreneurial space.
Roles have included founding CEO of NovaThera, founding Director of MedInnovate and founding industry consulting partner at Kinapse. She currently holds a number of chairmanships including Chair of CNBioInnovations (organs-on-chip transformative discovery technologies), Rephine Group (international GMP) and Parafricta (smart technology wound prevention). She is a Fellow of the Association of Pharmaceutical Scientists. Maureen’s life science knowledge, network, strategic insight and interest in developing people is invaluable to PIR and its strategic partners.